Fosaprepitant and Insulin lispro Subcutaneous
Determining the interaction of Fosaprepitant and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: n.a.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant-Insulin NPH
- Fosaprepitant-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Fosaprepitant-Insulin NPH (Vials)
- Fosaprepitant-Insulin NPH and Insulin Regular
- Fosaprepitant-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Fosaprepitant-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Fosaprepitant Injection
- Insulin lispro Subcutaneous-Fosaprepitant Intravenous
- Insulin lispro Subcutaneous-Foscarnet
- Insulin lispro Subcutaneous-Foscarnet Intravenous
- Insulin lispro Subcutaneous-Foscarnet Sodium
- Insulin lispro Subcutaneous-Foscavir